生存率-话题@MedSci

#生存率#

482篇内容 | 3059人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256745, encodeId=05171256e457e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=临床前实验证实：Itolizumab治疗移植物抗宿主病或可提高生存率并降低疾病严重性, objectType=article, longId=187000, objectId=38f418e00008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38f418e00008, replyNumber=0, likeNumber=74, createdTime=2020-02-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38f418e00008, moduleTitle=临床前实验证实：Itolizumab治疗移植物抗宿主病或可提高生存率并降低疾病严重性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38f418e00008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256744, encodeId=089d1256e44d2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJG：熊去氧胆酸可改善原发性胆源性胆管炎的整体生存率, objectType=article, longId=186860, objectId=b01118686063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b01118686063, replyNumber=0, likeNumber=62, createdTime=2020-01-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b01118686063, moduleTitle=AJG：熊去氧胆酸可改善原发性胆源性胆管炎的整体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b01118686063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256743, encodeId=73ff1256e4386, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=难治性晚期或复发性卵巢癌患者的III期试验：Opdivo（Nivolumab）未能改善总生存率, objectType=article, longId=186740, objectId=76ac186e40ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76ac186e40ac, replyNumber=0, likeNumber=55, createdTime=2020-01-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76ac186e40ac, moduleTitle=难治性晚期或复发性卵巢癌患者的III期试验：Opdivo（Nivolumab）未能改善总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76ac186e40ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256742, encodeId=7f0c1256e4256, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受, objectType=article, longId=186494, objectId=11b418649458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11b418649458, replyNumber=0, likeNumber=70, createdTime=2020-01-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11b418649458, moduleTitle=Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11b418649458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256741, encodeId=abe41256e4129, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=PLos One：院外心脏骤停后低温治疗可以提高选定患者的1年生存率, objectType=article, longId=186214, objectId=0ba6186214ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ba6186214ce, replyNumber=0, likeNumber=76, createdTime=2020-01-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ba6186214ce, moduleTitle=PLos One：院外心脏骤停后低温治疗可以提高选定患者的1年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ba6186214ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256740, encodeId=a2a41256e4028, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好, objectType=article, longId=186031, objectId=fef1186031b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef1186031b8, replyNumber=0, likeNumber=72, createdTime=2020-01-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef1186031b8, moduleTitle=Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef1186031b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256739, encodeId=8caa1256e3921, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=默沙东的Keytruda治疗小细胞肺癌的III期临床，未能明显改善患者的总体生存率, objectType=article, longId=185921, objectId=fcce18592178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcce18592178, replyNumber=0, likeNumber=115, createdTime=2020-01-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcce18592178, moduleTitle=默沙东的Keytruda治疗小细胞肺癌的III期临床，未能明显改善患者的总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcce18592178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256738, encodeId=b3cc1256e3896, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点, objectType=article, longId=185843, objectId=5f5518584350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5518584350, replyNumber=0, likeNumber=71, createdTime=2020-01-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5518584350, moduleTitle=默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5518584350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256737, encodeId=4b831256e3768, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Thorax：I期非小细胞肺癌肺叶切除术与立体定向消融放疗的治疗后生存率差异, objectType=article, longId=185826, objectId=3d6c18582600, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d6c18582600, replyNumber=0, likeNumber=67, createdTime=2020-01-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d6c18582600, moduleTitle=Thorax：I期非小细胞肺癌肺叶切除术与立体定向消融放疗的治疗后生存率差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d6c18582600)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256736, encodeId=51221256e3614, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Heart：艾森曼格综合征患者移植术后生存率研究, objectType=article, longId=185276, objectId=8b111852e6e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b111852e6e4, replyNumber=0, likeNumber=54, createdTime=2019-12-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b111852e6e4, moduleTitle=Heart：艾森曼格综合征患者移植术后生存率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b111852e6e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256735, encodeId=74971256e3570, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Rheum Dis：遗传风险评分高与系统性红斑狼疮起病早、损伤和生存率降低相关, objectType=article, longId=184755, objectId=3257184e55d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3257184e55d5, replyNumber=0, likeNumber=80, createdTime=2019-12-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3257184e55d5, moduleTitle=Ann Rheum Dis：遗传风险评分高与系统性红斑狼疮起病早、损伤和生存率降低相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3257184e55d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256734, encodeId=daf51256e347e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASH19：CC-486可显著提高AML患者的总生存率, objectType=article, longId=184564, objectId=3ba01845641d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ba01845641d, replyNumber=0, likeNumber=85, createdTime=2019-12-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ba01845641d, moduleTitle=ASH19：CC-486可显著提高AML患者的总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ba01845641d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256733, encodeId=09f81256e33d1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率, objectType=article, longId=184519, objectId=dec318451941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec318451941, replyNumber=0, likeNumber=85, createdTime=2019-12-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec318451941, moduleTitle=Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec318451941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256732, encodeId=5ae31256e324c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：生存偏倚可解释aSAH后吸烟者和高血压患者生存率改善, objectType=article, longId=182967, objectId=22fe18296edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22fe18296edc, replyNumber=0, likeNumber=67, createdTime=2019-11-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22fe18296edc, moduleTitle=Neurology：生存偏倚可解释aSAH后吸烟者和高血压患者生存率改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22fe18296edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256731, encodeId=7a701256e31d1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=【2019 ISRD-ATS】早筛早诊技术迎来突破，肺癌生存率有望不断提高, objectType=article, longId=182581, objectId=9f9718258148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9718258148, replyNumber=0, likeNumber=80, createdTime=2019-11-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9718258148, moduleTitle=【2019 ISRD-ATS】早筛早诊技术迎来突破，肺癌生存率有望不断提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9718258148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256730, encodeId=98a61256e305e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Inovio的INO-5401联合PD-1单抗cemiplimab治疗多形胶质母细胞瘤的2期研究，显示出80％的6个月无进展生存率, objectType=article, longId=182511, objectId=04741825119a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04741825119a, replyNumber=0, likeNumber=54, createdTime=2019-11-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04741825119a, moduleTitle=Inovio的INO-5401联合PD-1单抗cemiplimab治疗多形胶质母细胞瘤的2期研究，显示出80％的6个月无进展生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04741825119a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256729, encodeId=60ca1256e29e6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Respir J：脓毒症患者的生存率与外周血白细胞端粒长度有关, objectType=article, longId=181701, objectId=ec59181e0118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec59181e0118, replyNumber=0, likeNumber=65, createdTime=2019-10-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec59181e0118, moduleTitle=Eur Respir J：脓毒症患者的生存率与外周血白细胞端粒长度有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec59181e0118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256728, encodeId=44091256e289a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JACC：未经治疗的中重度主动脉瓣狭窄患者远期生存率低, objectType=article, longId=181539, objectId=853b1815399a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=853b1815399a, replyNumber=0, likeNumber=75, createdTime=2019-10-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=853b1815399a, moduleTitle=JACC：未经治疗的中重度主动脉瓣狭窄患者远期生存率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=853b1815399a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256727, encodeId=66781256e27b2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果, objectType=article, longId=180885, objectId=c2e718088544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e718088544, replyNumber=0, likeNumber=122, createdTime=2019-10-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e718088544, moduleTitle=K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2e718088544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256726, encodeId=735b1256e267e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2019年ESMO：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率, objectType=article, longId=180572, objectId=59da1805e210, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59da1805e210, replyNumber=0, likeNumber=77, createdTime=2019-10-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59da1805e210, moduleTitle=2019年ESMO：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59da1805e210)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

临床前实验证实：Itolizumab治疗移植物抗宿主病或可提高生存率并降低疾病严重性

2020-02-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJG：熊去氧胆酸可改善原发性胆源性胆管炎的整体生存率

2020-01-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

难治性晚期或复发性卵巢癌患者的III期试验：Opdivo（Nivolumab）未能改善总生存率

2020-01-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受

2020-01-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

PLos One：院外心脏骤停后低温治疗可以提高选定患者的1年生存率

2020-01-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Sci Rep：高CD3和ICOS及低TIM-3表达预测食管鳞状细胞癌切除后的生存率良好

2020-01-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

默沙东的Keytruda治疗小细胞肺癌的III期临床，未能明显改善患者的总体生存率

2020-01-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点

2020-01-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Thorax：I期非小细胞肺癌肺叶切除术与立体定向消融放疗的治疗后生存率差异

2020-01-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Heart：艾森曼格综合征患者移植术后生存率研究

2019-12-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Rheum Dis：遗传风险评分高与系统性红斑狼疮起病早、损伤和生存率降低相关

2019-12-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASH19：CC-486可显著提高AML患者的总生存率

2019-12-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率

2019-12-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：生存偏倚可解释aSAH后吸烟者和高血压患者生存率改善

2019-11-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

【2019 ISRD-ATS】早筛早诊技术迎来突破，肺癌生存率有望不断提高

2019-11-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Inovio的INO-5401联合PD-1单抗cemiplimab治疗多形胶质母细胞瘤的2期研究，显示出80％的6个月无进展生存率

2019-11-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Respir J：脓毒症患者的生存率与外周血白细胞端粒长度有关

2019-10-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JACC：未经治疗的中重度主动脉瓣狭窄患者远期生存率低

2019-10-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果

2019-10-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2019年ESMO：Ivosidenib显著改善晚期mIDH1胆管癌患者的生存率

2019-10-07

科室
- - 订阅+
  - 更多科室
工具
服务